Successful rechallenge with taxanes following prophylactic ketotifen in patients who had developed severe hypersensitivity reactions.
Briasoulis
E
E
Karavasilis
V
V
Pavlidis
N
N
D000328:Adult; D000368:Aged; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects / Q000276:immunology*; D000077143:Docetaxel; D004342:Drug Hypersensitivity / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007665:Ketotifen / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D017239:Paclitaxel / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000276:immunology*; D010865:Pilot Projects; D043823:Taxoids
D018926:Anti-Allergic Agents; D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel; D007665:Ketotifen